{"id":315201,"date":"2024-02-24T13:00:48","date_gmt":"2024-02-24T07:30:48","guid":{"rendered":"https:\/\/www.scconline.com\/blog\/?p=315201"},"modified":"2024-02-24T14:29:19","modified_gmt":"2024-02-24T08:59:19","slug":"shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited","status":"publish","type":"post","link":"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/","title":{"rendered":"Shardul Amarchand Mangaldas & Co. advises Eris Lifesciences Limited on the acquisition of a majority stake in Swiss Parenterals Limited"},"content":{"rendered":"
\n

Shardul Amarchand Mangaldas advised Eris Lifesciences Limited (“Eris<\/span>”) on the acquisition of a majority stake in Swiss Parenterals Limited (“SPL<\/span>”) from the existing shareholders of SPL by Eris and certain individual purchasers. The aggregate deal value is approximately INR 875 Crores (USD 105.38 million). The consideration was paid through a combination of cash consideration and issuance by Eris of secured, redeemable non-convertible debentures.<\/p>\n

After completion of the transaction, Eris holds 51% of the share capital of SPL and the individual purchasers, collectively, hold ~19% of the share capital of SPL.<\/p>\n

The transaction augments the capability of Eris in the sterile injectables segment.<\/p>\n

The transaction team was led by Nivedita Tiwari, Partner; Devesh Pandey, Partner; Shailesh Singh, Principal Associate; and Anushka Ganguli, Associate.<\/p>\n

The financing team was led by Shilpa Mankar Ahluwalia, Partner; Shubhangi Garg, Partner; Utsav Dubey, Principal Associate; Purva Anand, Associate; and Gunjan Shrivastav, Associate.<\/p>\n

Tax team was led by Gouri Puri, Partner and Rahul Yadav, Counsel.<\/p>\n

Ritwik Bhattacharya, Partner advised on the competition law aspects.<\/p>\n

SPL and the Sellers were advised by Cyril Amarchand Mangaldas on the legal aspects.<\/p>\n

About Shardul Amarchand Mangaldas & Co:<\/p>\n

Shardul Amarchand Mangaldas & Co., founded on a century of legal achievements, is one of India’s leading full-service law firms. The Firm’s mission is to enable business by providing solutions as trusted advisers through excellence, responsiveness, innovation, and collaboration. SAM & Co. is known globally for its exceptional practices in mergers & acquisitions, private equity, competition law, insolvency & bankruptcy, dispute resolution, international commercial arbitration, capital markets, banking & finance, tax, intellectual property, data protection and data privacy, technology law and projects & infrastructure.<\/p>\n

The Firm has a pan-India presence and has been at the helm of major headline transactions and litigations in all sectors, besides advising major multinational corporates on their entry into the Indian market and their business strategy. Currently, the Firm has over 824 lawyers including 165 Partners, offering legal services through its offices in New Delhi, Mumbai, Gurugram, Ahmedabad, Kolkata, Bengaluru, and Chennai.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Shardul Amarchand Mangaldas advised Eris Lifesciences Limited (“Eris”) on the acquisition of a majority stake in Swiss Parenterals Limited (“SPL”) from the <\/p>\n","protected":false},"author":8808,"featured_media":315247,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[45282,2],"tags":[63298,65707,61012,46701,65706],"class_list":["post-315201","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-firms-news","category-news","tag-eris-lifesciences-limited","tag-eris-of-secured","tag-majority-stake","tag-shardul-amarchand-mangaldas","tag-swiss-parenterals-limited"],"yoast_head":"\nShardul Amarchand Mangaldas & Co. advises Eris Lifesciences Limited on the acquisition of a majority stake in Swiss Parenterals Limited | SCC Times<\/title>\n<meta name=\"description\" content=\"Shardul Amarchand Mangaldas advised Eris Lifesciences Limited (\u201cEris\u201d) on the acquisition of a majority stake in Swiss Parenterals Limited\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shardul Amarchand Mangaldas & Co. advises Eris Lifesciences Limited on the acquisition of a majority stake in Swiss Parenterals Limited\" \/>\n<meta property=\"og:description\" content=\"Shardul Amarchand Mangaldas advised Eris Lifesciences Limited (\u201cEris\u201d) on the acquisition of a majority stake in Swiss Parenterals Limited\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/\" \/>\n<meta property=\"og:site_name\" content=\"SCC Times\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/scc.online\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-24T07:30:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-24T08:59:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Eris-Lifesciences-Limited.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"886\" \/>\n\t<meta property=\"og:image:height\" content=\"590\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Bhumika Indulia\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Shardul Amarchand Mangaldas & Co. advises Eris Lifesciences Limited on the acquisition of a majority stake in Swiss Parenterals Limited\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Bhumika Indulia\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/\",\"url\":\"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/\",\"name\":\"Shardul Amarchand Mangaldas & Co. advises Eris Lifesciences Limited on the acquisition of a majority stake in Swiss Parenterals Limited | SCC Times\",\"isPartOf\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Eris-Lifesciences-Limited.webp\",\"datePublished\":\"2024-02-24T07:30:48+00:00\",\"dateModified\":\"2024-02-24T08:59:19+00:00\",\"author\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/919ec47cc1b871b362af05740398033a\"},\"description\":\"Shardul Amarchand Mangaldas advised Eris Lifesciences Limited (\u201cEris\u201d) on the acquisition of a majority stake in Swiss Parenterals Limited\",\"breadcrumb\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/#primaryimage\",\"url\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Eris-Lifesciences-Limited.webp\",\"contentUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Eris-Lifesciences-Limited.webp\",\"width\":886,\"height\":590,\"caption\":\"Eris Lifesciences Limited\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.scconline.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shardul Amarchand Mangaldas & Co. advises Eris Lifesciences Limited on the acquisition of a majority stake in Swiss Parenterals Limited\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\",\"url\":\"https:\/\/www.scconline.com\/blog\/\",\"name\":\"SCC Times\",\"description\":\"Bringing you the Best Analytical Legal News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.scconline.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/919ec47cc1b871b362af05740398033a\",\"name\":\"Bhumika Indulia\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2021\/04\/Me-150x150.jpg\",\"contentUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2021\/04\/Me-150x150.jpg\",\"caption\":\"Bhumika Indulia\"},\"url\":\"https:\/\/www.scconline.com\/blog\/post\/author\/editor_1\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Shardul Amarchand Mangaldas & Co. advises Eris Lifesciences Limited on the acquisition of a majority stake in Swiss Parenterals Limited | SCC Times","description":"Shardul Amarchand Mangaldas advised Eris Lifesciences Limited (\u201cEris\u201d) on the acquisition of a majority stake in Swiss Parenterals Limited","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/","og_locale":"en_US","og_type":"article","og_title":"Shardul Amarchand Mangaldas & Co. advises Eris Lifesciences Limited on the acquisition of a majority stake in Swiss Parenterals Limited","og_description":"Shardul Amarchand Mangaldas advised Eris Lifesciences Limited (\u201cEris\u201d) on the acquisition of a majority stake in Swiss Parenterals Limited","og_url":"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/","og_site_name":"SCC Times","article_publisher":"https:\/\/www.facebook.com\/scc.online\/","article_published_time":"2024-02-24T07:30:48+00:00","article_modified_time":"2024-02-24T08:59:19+00:00","og_image":[{"width":886,"height":590,"url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Eris-Lifesciences-Limited.jpg","type":"image\/jpeg"}],"author":"Bhumika Indulia","twitter_card":"summary_large_image","twitter_title":"Shardul Amarchand Mangaldas & Co. advises Eris Lifesciences Limited on the acquisition of a majority stake in Swiss Parenterals Limited","twitter_misc":{"Written by":"Bhumika Indulia","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/","url":"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/","name":"Shardul Amarchand Mangaldas & Co. advises Eris Lifesciences Limited on the acquisition of a majority stake in Swiss Parenterals Limited | SCC Times","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/#primaryimage"},"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Eris-Lifesciences-Limited.webp","datePublished":"2024-02-24T07:30:48+00:00","dateModified":"2024-02-24T08:59:19+00:00","author":{"@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/919ec47cc1b871b362af05740398033a"},"description":"Shardul Amarchand Mangaldas advised Eris Lifesciences Limited (\u201cEris\u201d) on the acquisition of a majority stake in Swiss Parenterals Limited","breadcrumb":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/#primaryimage","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Eris-Lifesciences-Limited.webp","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Eris-Lifesciences-Limited.webp","width":886,"height":590,"caption":"Eris Lifesciences Limited"},{"@type":"BreadcrumbList","@id":"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.scconline.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Shardul Amarchand Mangaldas & Co. advises Eris Lifesciences Limited on the acquisition of a majority stake in Swiss Parenterals Limited"}]},{"@type":"WebSite","@id":"https:\/\/www.scconline.com\/blog\/#website","url":"https:\/\/www.scconline.com\/blog\/","name":"SCC Times","description":"Bringing you the Best Analytical Legal News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.scconline.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/919ec47cc1b871b362af05740398033a","name":"Bhumika Indulia","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2021\/04\/Me-150x150.jpg","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2021\/04\/Me-150x150.jpg","caption":"Bhumika Indulia"},"url":"https:\/\/www.scconline.com\/blog\/post\/author\/editor_1\/"}]}},"jetpack_featured_media_url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Eris-Lifesciences-Limited.webp","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":368864,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/","url_meta":{"origin":315201,"position":0},"title":"Shardul Amarchand Mangaldas Advises Eris Lifesciences Limited on the Acquisition of Remaining Stake in Swiss Parenterals Limited","author":"Editor","date":"December 5, 2025","format":false,"excerpt":"SAM advised Eris Lifesciences on acquiring the remaining 30% stake in Swiss Parenterals, making it a wholly owned subsidiary.","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Eris Lifesciences Swiss Parenterals acquisition","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Eris-Lifesciences-Swiss-Parenterals-acquisition.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Eris-Lifesciences-Swiss-Parenterals-acquisition.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Eris-Lifesciences-Swiss-Parenterals-acquisition.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Eris-Lifesciences-Swiss-Parenterals-acquisition.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":369143,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/08\/cam-advises-swiss-parenterals-30-percent-stake-acquisition-eris-lifesciences-2025\/","url_meta":{"origin":315201,"position":1},"title":"Cyril Amarchand Mangaldas advises Swiss Parenterals Limited in acquisition of its 30% stake by Eris Lifesciences Limited","author":"Editor","date":"December 8, 2025","format":false,"excerpt":"Cyril Amarchand Mangaldas advised Swiss Parenterals Limited and its promoter on the sale of the remaining 30% stake to Eris Lifesciences Limited through a preferential allotment deal worth \u20b9423.30 crore.","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"CAM Swiss Parenterals Eris Lifesciences acquisition","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Swiss-Parenterals-Eris-Lifesciences-acquisition.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Swiss-Parenterals-Eris-Lifesciences-acquisition.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Swiss-Parenterals-Eris-Lifesciences-acquisition.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Swiss-Parenterals-Eris-Lifesciences-acquisition.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":308625,"url":"https:\/\/www.scconline.com\/blog\/post\/2023\/12\/07\/sam-advises-eris-lifesciences-limited-acquisition-of-dermatology-and-nephrology-branded-formulations-business-units\/","url_meta":{"origin":315201,"position":2},"title":"SAM advises Eris Lifesciences Limited on its acquisition of Dermatology and Nephrology branded formulations business units of Biocon Biologics Limited in India","author":"Bhumika Indulia","date":"December 7, 2023","format":false,"excerpt":"Shardul Amarchand Mangaldas advised Eris Lifesciences Limited (\u201cEris\u201d) on its acquisition of Dermatology and Nephrology branded formulations business units of Biocon Biologics Limited (\u201cBiocon\u201d) in India. The deal is valued at approximately INR 366 crores and the date of closing the deal was 10 November 2023. This acquisition marks the\u2026","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Eris Lifesciences Limited","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/12\/Texmaco-Rail-Engineering-Limited.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/12\/Texmaco-Rail-Engineering-Limited.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/12\/Texmaco-Rail-Engineering-Limited.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/12\/Texmaco-Rail-Engineering-Limited.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":287398,"url":"https:\/\/www.scconline.com\/blog\/post\/2023\/03\/21\/khaitan-co-advises-eris-lifesciences-limited-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-dr-reddys-laboratories-limited\/","url_meta":{"origin":315201,"position":3},"title":"Khaitan & Co advises Eris Lifesciences Limited on its acquisition of a part of the dermatology portfolio of Dr. Reddy’s Laboratories Limited","author":"Bhumika Indulia","date":"March 21, 2023","format":false,"excerpt":"Khaitan & Co has advised Eris Lifesciences Limited on its acquisition of a part of the dermatology portfolio of Dr. Reddy's Laboratories Limited for a total consideration of INR 275 crores. The acquisition helps augment and expand the dermatology business of Eris Lifesciences in India. The team assisted in drafting,\u2026","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/03\/MicrosoftTeams-image-811.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/03\/MicrosoftTeams-image-811.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/03\/MicrosoftTeams-image-811.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/03\/MicrosoftTeams-image-811.png?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":283450,"url":"https:\/\/www.scconline.com\/blog\/post\/2023\/02\/08\/khaitan-co-advises-eris-group-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-glenmark-pharmaceuticals-limited\/","url_meta":{"origin":315201,"position":4},"title":"Khaitan & Co. advises Eris Group on its acquisition of a part of the dermatology portfolio of Glenmark Pharmaceuticals Limited","author":"Bhumika Indulia","date":"February 8, 2023","format":false,"excerpt":"DEAL DETAILS Eris Lifesciences Limited | Brand agreement and supply of agreement between Eris Lifesciences Limited and Glenmark Pharmaceuticals Limited NO HEADINGS DETAILS 1. Sector Pharmaceutical Industry 2. Announcement Date 17-Jan-2023 3. Completion Date 17-Jan-2023 4. Name of Client Eris Lifesciences Limited Eris Lifesciences Ltd is a publicly listed Indian\u2026","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/02\/MicrosoftTeams-image-339.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":317745,"url":"https:\/\/www.scconline.com\/blog\/post\/2024\/03\/19\/khaitan-co-advises-eris-lifesciences-limited-on-its-acquisition-of-the-branded-formulations-business-of-biocon-biologics-limited-in-india\/","url_meta":{"origin":315201,"position":5},"title":"Khaitan & Co advises Eris Lifesciences Limited on its acquisition of the branded formulations business of Biocon Biologics Limited in India","author":"Bhumika Indulia","date":"March 19, 2024","format":false,"excerpt":"DEAL DETAILS Eris Lifesciences Limited | Acquisition of the Indian branded formulations business of Biocon Biologics Limited Khaitan & Co advised Eris Lifesciences Limited on its acquisition of the branded formulations business of Biocon Biologics Limited in India for a total consideration of INR 1,242 Crores. The acquisition helps augment\u2026","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Eris Lifesciences Limited","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/03\/biocon.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/03\/biocon.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/03\/biocon.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/03\/biocon.webp?resize=700%2C400&ssl=1 2x"},"classes":[]}],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/315201","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/users\/8808"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/comments?post=315201"}],"version-history":[{"count":0,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/315201\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media\/315247"}],"wp:attachment":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media?parent=315201"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/categories?post=315201"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/tags?post=315201"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}